Last update :
Stability and compatibility of drugs
Welcome in Stabilis. If you wish to receive the quarterly newsletter, indicate your email address.

If you have any questions or comments, please contact :
References : 2102
Compounds : 743
Pharmacological Class : 40
Stability of solutions : 4532
Stability in mixtures : 981
Incompatibilities : 2766
Trade Name : 1937
News - Compounds  
Cytostatic Injection Nivolumab 24/08/2016
Various Injection Tranexamic acid 24/08/2016
Various Ointments 8-methoxypsoralen 04/08/2016
Antiepileptic Injection Valproic acid 03/07/2016
Anti-inflammatory Injection Betamethasone sodium phosphate 05/06/2016
Vitamin Injection Cyanocobalamine 05/06/2016
Various Injection Thiocolchicoside 05/06/2016
Various Injection Ferric carboxymaltose 05/06/2016
Various Oral solution Levodopa/Carbidopa 22/05/2016
Antidepressant Oral solution Imipramine hydrochloride 22/05/2016
Anxiolytic Oral solution Lorazepam 22/05/2016
Antibiotic Oral solution Minocycline hydrochloride 22/05/2016
Anti-inflammatory Oral solution Penicillamine-D 22/05/2016
Anti-inflammatory Oral solution Ketoprofen 22/05/2016
Antiepileptic Oral solution Clonazepam 22/05/2016
General anesthetic Oral solution Pentobarbital 21/05/2016
Analgesic Oral solution Morphine sulfate 21/05/2016
Antiepileptic Injection Levetiracetam 16/05/2016
Various Oral solution Proflavine 12/03/2016
Immunosuppressant Oral solution Azathioprine 12/03/2016
News - References  
Date of Entry
3868 Incompatibility of busulfan with 1 ml Luer-Lock syringes. J Oncol Pharm Practice 19/05/2016
3865 Compatibility of Norepinephrine Bitartrate with Levofloxacin and Moxifloxacin During Simulated Y-site Administration. Int J Pharm Compound 17/05/2016
3866 Extended Stability of Morphine and Sildenafil for Oral Use in Infants and Young Children. Int J Pharm Compound 17/05/2016
3863 Nivolumab (Opdivo®) - Summary of Products characteristics Bristol Myers Squibb 29/04/2016
3862 Enzymatic Stability of Alteplase Solution for Injection: Effect of Various Methods of Thawing Frozen Solutions. Hosp Pharm 22/04/2016
3860 Stability of trimethoprim in newly formulated liquid dosage form. J Pharm Pract and Res 18/04/2016
3861 Evaluation of stability of melatonin in extemporaneously compounded oral suspensions. J Pharm Pract and Res 18/04/2016
3859 Microbiological and Physico-Chemical Stability of Ketamine Solution for Patient-Controlled Analgesia Systems. RRJHCP 16/04/2016
3857 Stability of Atenolol, Clonazepam, Dexamethasone, Diclofenac Sodium, Diltiazem, Enalapril Maleate, Ketoprofen, Lamotrigine, Penicillamine-D, and Thiamine in SyrSpend SF PH4 Oral Suspensions Int J Pharm Compound 08/04/2016
3854 Stability of extemporaneously compounded trimethioprim in glass and plastic bottles and plstic syringes. Can J Hosp Pharm 14/03/2016
3851 Dexamethasone 1 mg/mL Suspension Prepared from Crushed Tablets: Stability in Glass and Plastic Bottles and Plastic Syringes. Can J Hosp Pharm 02/03/2016
3850 Stability of ipilimumab in its original vial after opening allows its use for at least 4 weeks and facilitates pooling of residues. Eur J Cancer 26/02/2016
3840 Stability of cefpirome sulfate in aqueous solutions. Acta Pol Pharm 17/02/2016
3841 Visual and absorbance analyses of admixtures containing vancomycin and piperacillin–tazobactam at commonly used concentrations. Am J Health-Syst Pharm 17/02/2016
3842 Stability of tacrolimus solutions in polyolefin containers. Am J Health-Syst Pharm 17/02/2016
3843 Evaluation of the Stability of Mercaptopurine Suspension Compounded in a Commercial Vehicle and the Determination of an Appropriate Beyond-use Date. Int J Pharm Compound 17/02/2016
3844 Stability and Osmolality of Extemporaneously Prepared Clonidine Oral Liquid for Neonates. Ann Pharmacotherapy 17/02/2016
3845 Stability of Pentobarbital in Water and Oral Pediatric Suspensions. Ann Pharmacotherapy 17/02/2016
3846 Compatibility of cholecalciferol, haloperidol, imipramine hydrochloride, levodopa/carbidopa, lorazepam, minocycline hydrochloride, tacrolimus monohydrate, terbinafine, tramadol hydrochloride and valsartan in SyrSpend® SF PH4 oral suspensions. Pharmazie 17/02/2016
3847 A Pilot Chemical and Physical Stability Study of Extemporaneously Compounded Levetiracetam Intravenous Solution. J Pain Palliat Care Pharm 17/02/2016
3848 Etude de stabilité d'un collyre à l'amphotéricine B 0,5%. Thèse de doctorat en pharmacie 17/02/2016
3849 Physical and structural stability of the monoclonal antibody, trastuzumab (Herceptin®), intravenous solutions. Curr Pharm Biotech 17/02/2016
3839 Post-reconstitution Stability of Telavancin with Commonly Used Diluents and Intravenous Infusion Solutions. Current Ther Res 12/02/2016
3838 Magnesium Sulphate BP Injection 1g/10ml : Summary of Product Characteristics Martindale Pharmaceuticals Ltd 11/02/2016
3837 Stability of meropenem in normal saline solution after storage at room temperature. South Asian J Trop Med Pub Health 10/02/2016
3835 Chemical Stability of Telavancin in Elastomeric Pumps. Current Ther Res 07/02/2016
3830 Stability study of carboplatin infusion solutions in 0.9% sodium chloride in polyvinyl chloride bags. J Oncol Pharm Practice 14/01/2016
3832 Stability Studies of Extemporaneously Compounded Clobazam Oral Suspension. Ann Pharmacotherapy 14/01/2016
3827 Compatibility of tedilozid phosphate with selected intravenous drugs via simulated Y-site conditions. ASHP Midyear 2015 05/01/2016
3828 Ceftozolane/tazobactam physical compatibility during simulated Y-site administration. ASHP Midyear 2015 05/01/2016

Temps de calcul serveur : 129 millisecondes